Literature DB >> 26137166

Securin promotes migration and invasion via matrix metalloproteinases in glioma cells.

Haicheng Yan1, Wei Wang2, Changwu Dou3, Fuming Tian3, Songtao Qi1.   

Abstract

Human securin, encoded by pituitary tumor transforming gene 1, is implicated in several oncogenic processes in the pathogenesis of brain tumors, including glioma. The aim of the present study was to examine the effect of securin on the migration and invasion of glioma cells. The results revealed that the overexpression of securin in glioma LN-229 cells significantly increased the invasion and transmigration abilities. By contrast, these abilities were significantly reduced by the downregulation of securin in glioma U373 cells. Furthermore, the results demonstrated that securin overexpression and downregulation significantly increased and decreased the levels of matrix metalloproteinase 2 and 9, respectively. These findings indicate a promotive role for securin in glioma migration and invasion, which may involve the action of matrix metalloproteinases.

Entities:  

Keywords:  glioma; matrix metalloproteinase; pituitary tumor transforming gene 1; securin

Year:  2015        PMID: 26137166      PMCID: PMC4473712          DOI: 10.3892/ol.2015.3074

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  40 in total

1.  Pituitary tumor transforming gene and fibroblast growth factor-2 expression: potential prognostic indicators in differentiated thyroid cancer.

Authors:  K Boelaert; C J McCabe; L A Tannahill; N J L Gittoes; R L Holder; J C Watkinson; A R Bradwell; M C Sheppard; J A Franklyn
Journal:  J Clin Endocrinol Metab       Date:  2003-05       Impact factor: 5.958

2.  Role of pituitary tumour transforming gene 1 in medullary thyroid carcinoma.

Authors:  Maria Chiara Zatelli; Federico Tagliati; Vincenzo Amodio; Mattia Buratto; Mariarosa Pelizzo; Giancarlo Pansini; Marta Bondanelli; Maria Rosaria Ambrosio; Ettore C Degli Uberti
Journal:  Anal Cell Pathol (Amst)       Date:  2010       Impact factor: 2.916

3.  Downregulation of Securin by the variant RNF213 R4810K (rs112735431, G>A) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from moyamoya patients.

Authors:  Toshiaki Hitomi; Toshiyuki Habu; Hatasu Kobayashi; Hiroko Okuda; Kouji H Harada; Kenji Osafune; Daisuke Taura; Masakatsu Sone; Isao Asaka; Tomonaga Ameku; Akira Watanabe; Tomoko Kasahara; Tomomi Sudo; Fumihiko Shiota; Hirokuni Hashikata; Yasushi Takagi; Daisuke Morito; Susumu Miyamoto; Kazuwa Nakao; Akio Koizumi
Journal:  Biochem Biophys Res Commun       Date:  2013-07-12       Impact factor: 3.575

4.  Overexpression of pituitary tumor transforming gene (PTTG) is associated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.

Authors:  Jinfeng Zhang; Yingnan Yang; Lantao Chen; Dayong Zheng; Jianqun Ma
Journal:  Acta Histochem       Date:  2013-10-28       Impact factor: 2.479

5.  Structure, expression, and function of human pituitary tumor-transforming gene (PTTG).

Authors:  X Zhang; G A Horwitz; T R Prezant; A Valentini; M Nakashima; M D Bronstein; S Melmed
Journal:  Mol Endocrinol       Date:  1999-01

6.  Molecular cloning, genomic organization, and identification of the promoter for the human pituitary tumor transforming gene (PTTG).

Authors:  S S Kakar
Journal:  Gene       Date:  1999-11-29       Impact factor: 3.688

7.  Klotho suppresses growth and invasion of colon cancer cells through inhibition of IGF1R-mediated PI3K/AKT pathway.

Authors:  Xin-Xiang Li; Li-Yong Huang; Jun-Jie Peng; Lei Liang; De-Bing Shi; Hong-Tu Zheng; San-Jun Cai
Journal:  Int J Oncol       Date:  2014-05-09       Impact factor: 5.650

8.  PTTG1 overexpression in adrenocortical cancer is associated with poor survival and represents a potential therapeutic target.

Authors:  Michael J Demeure; Kathryn E Coan; Clive S Grant; Richard A Komorowski; Elizabeth Stephan; Shripad Sinari; David Mount; Kimberly J Bussey
Journal:  Surgery       Date:  2013-12       Impact factor: 3.982

9.  Expression of pituitary tumor-transforming gene in endometrial cancer as a prognostic marker.

Authors:  J W Kim; J Y Song; J M Lee; J K Lee; N W Lee; B W Yeom; K W Lee
Journal:  Int J Gynecol Cancer       Date:  2008-01-22       Impact factor: 3.437

10.  Cdc20 and securin overexpression predict short-term breast cancer survival.

Authors:  H Karra; H Repo; I Ahonen; E Löyttyniemi; R Pitkänen; M Lintunen; T Kuopio; M Söderström; P Kronqvist
Journal:  Br J Cancer       Date:  2014-05-22       Impact factor: 7.640

View more
  10 in total

1.  Differentially Expressed Long Non-Coding RNAs Were Predicted to Be Involved in the Control of Signaling Pathways in Pediatric Astrocytoma.

Authors:  Ruth Ruiz Esparza-Garrido; Juan Manuel Rodríguez-Corona; Javier Enrique López-Aguilar; Marco Antonio Rodríguez-Florido; Ana Claudia Velázquez-Wong; Rubí Viedma-Rodríguez; Fabio Salamanca-Gómez; Miguel Ángel Velázquez-Flores
Journal:  Mol Neurobiol       Date:  2016-10-13       Impact factor: 5.590

2.  Overexpression of ubiquitin specific proteases 44 promotes the malignancy of glioma by stabilizing tumor-promoter securin.

Authors:  Yongxiang Zou; Guanzhong Qiu; Lei Jiang; Zheng Cai; Wei Sun; Hongkang Hu; Chengyin Lu; Weilin Jin; Guohan Hu
Journal:  Oncotarget       Date:  2017-03-22

3.  The function of MMP-28/TGF-β induced cell apoptosis in human glioma cells.

Authors:  Xuepeng Wang; Xi Chen; Lin Sun; Xiaoli Bi; Haitao He; Lei Chen; Jinfeng Pang
Journal:  Exp Ther Med       Date:  2018-08-02       Impact factor: 2.447

4.  Evaluation of serum extracellular vesicles as noninvasive diagnostic markers of glioma.

Authors:  Huayi Wang; Dengzhi Jiang; Wenzhe Li; Xiang Xiang; Jun Zhao; Bin Yu; Chen Wang; Zhaohui He; Ling Zhu; Yanlian Yang
Journal:  Theranostics       Date:  2019-07-09       Impact factor: 11.556

5.  A Comprehensive Pan-Cancer Analysis for Pituitary Tumor-Transforming Gene 1.

Authors:  Siming Gong; Changwu Wu; Yingjuan Duan; Juyu Tang; Panfeng Wu
Journal:  Front Genet       Date:  2022-02-25       Impact factor: 4.599

6.  Clinical significance of securin expression in solid cancers: A PRISMA-compliant meta-analysis of published studies and bioinformatics analysis based on TCGA dataset.

Authors:  Xiang Liu; Wei Zeng; Dayang Zheng; Min Tang; Wangyan Zhou
Journal:  Medicine (Baltimore)       Date:  2022-09-16       Impact factor: 1.817

Review 7.  Matrix metalloproteinase-9 and -2 and tissue inhibitor of matrix metalloproteinase-2 in invasive pituitary adenomas: A systematic review and meta-analysis of case-control trials.

Authors:  Hong-Yan Liu; Wei-Jun Gu; Cheng-Zhi Wang; Xiao-Jian Ji; Yi-Ming Mu
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

8.  Targeting the PTTG1 oncogene impairs proliferation and invasiveness of melanoma cells sensitive or with acquired resistance to the BRAF inhibitor dabrafenib.

Authors:  Simona Caporali; Ester Alvino; Pedro Miguel Lacal; Federica Ruffini; Lauretta Levati; Laura Bonmassar; Alessandro Scoppola; Paolo Marchetti; Simona Mastroeni; Gian Carlo Antonini Cappellini; Stefania D'Atri
Journal:  Oncotarget       Date:  2017-12-09

9.  Exosomes derived from microRNA-584 transfected mesenchymal stem cells: novel alternative therapeutic vehicles for cancer therapy.

Authors:  Ran Kim; Seokyeon Lee; Jihyun Lee; Minji Kim; Won Jung Kim; Hee Won Lee; Min Young Lee; Jongmin Kim; Woochul Chang
Journal:  BMB Rep       Date:  2018-08       Impact factor: 4.778

10.  The pituitary tumour-transforming gene 1/delta-like homologue 1 pathway plays a key role in liver fibrogenesis.

Authors:  Meritxell Perramón; Silvia Carvajal; Vedrana Reichenbach; Guillermo Fernández-Varo; Loreto Boix; Laura Macias-Muñoz; Pedro Melgar-Lesmes; Jordi Bruix; Shlomo Melmed; Santiago Lamas; Wladimiro Jiménez
Journal:  Liver Int       Date:  2022-01-30       Impact factor: 8.754

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.